ArticleCureus2026
Exogenous Ochronosis Masquerading As Melasma in Skin of Color: Indications for Early Detection and Updated Clinical Review of Diagnosis, Pathomechanism, and Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exogenous ochronosis (EO) is an uncommon but potentially disfiguring complication of prolonged topical hydroquinone use. It occurs most frequently in individuals with darker skin types and may clinically resemble melasma, often leading to delayed recognition and continued exposure to the offending agent. A 66-year-old female with Fitzpatrick skin type V presented with progressive facial hyperpigmentation, initially diagnosed as melasma and treated with repeated courses of topical hydroquinone. Despite therapy, pigmentation darkened over time, developing a slate-gray to blue-black discoloration. Reevaluation raised concern for EO based on clinical features and paradoxical worsening with continued treatment. Hydroquinone was discontinued, and the patient was treated with topical retinoids and strict photoprotection, resulting in stabilization of pigmentation at follow-up. Exogenous ochronosis remains an underrecognized diagnosis and a common source of iatrogenic progression when misclassified as treatment-resistant melasma. This case highlights a common diagnostic pitfall and provides clinical images and practical guidance for earlier recognition and management of EO in patients with skin of color.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.